Outcomes of Combined Cataract Surgery With Retinal Surgery for Visually Significant Epiretinal Membrane With Vivity Versus Monofocal Intraocular Lens
NCT ID: NCT07070492
Last Updated: 2025-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
36 participants
INTERVENTIONAL
2025-07-31
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual Outcomes and Patient Satisfaction With Vivity IOL in Post Refractive Patients
NCT06064916
Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach
NCT05821101
Blue-Blocking IOLs in Combined Surgery
NCT00537992
Vivity IOL: Emmetropia Compared to Monovision.
NCT05464732
Surgical Outcomes After Routine Cataract Extraction & Implantation of a Conventional or Spheric Intraocular Lens
NCT00366496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vivity Extended Depth of Focus IOL
cataract surgery
cataract surgery receiving Vivity IOL or standard mono focal controls
retinal surgery
Retinal surgery for visually significant epiretinal membrane
Standard monofocal IOL
cataract surgery
cataract surgery receiving Vivity IOL or standard mono focal controls
retinal surgery
Retinal surgery for visually significant epiretinal membrane
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cataract surgery
cataract surgery receiving Vivity IOL or standard mono focal controls
retinal surgery
Retinal surgery for visually significant epiretinal membrane
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* IOL powers between +6D to +30.0D, T3-T6
Exclusion Criteria
* Other ocular or systemic comorbidities that may alter or reduce visual acuity and contrast sensitivity, such as severe dry eye/ocular surface disease, glaucoma, macular degeneration, retinopathy, neuro-ophthalmic diseases, strabismus/amblyopia etc.
* Patients with irregular astigmatism, corneal dystrophies, pupil abnormalities, zonular laxity
* Intraoperative or postoperative complications
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Debbie Kuo, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Debbie Kuo, MD
Palo Alto Foundation Medical Group affiliated Ophthalmologist
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025.067-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.